Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 63,230 | 0 | 42,060 | 41,390 | 247,380 |
| Cost of Goods | 16,500 | N/A | 12,930 | 11,740 | 156,360 |
| Gross Profit | 46,730 | 19,200 | 29,130 | 29,640 | 91,020 |
| Operating Expenses | 71,190 | 57,100 | 66,130 | 56,040 | 77,590 |
| Operating Income | -23,960 | -57,100 | -36,070 | -25,650 | 13,790 |
| Interest Expense | 5 | 0 | 80 | 1,450 | 9,780 |
| Other Income | -755 | 0 | 2,160 | 5,280 | 1,950 |
| Pre-tax Income | -24,720 | -57,100 | -33,990 | -21,820 | 5,960 |
| Income Tax | 0 | N/A | -1,960 | -29,120 | 7,330 |
| Net Income Continuous | -24,724 | -59,817 | -32,037 | -21,830 | -8,429 |
| Net Income Discontinuous | 0 | N/A | -250 | 26,090 | 0 |
| Net Income | $-24,720 | $-59,817 | $-32,290 | $33,390 | $10,570 |
| EPS Basic Total Ops | -25,794.84 | -67,186.56 | -36,592.68 | 38,392.30 | 13,797.20 |
| EPS Basic Continuous Ops | -27,471.11 | -66,463.34 | -35,596.66 | -24,255.55 | -10,536.25 |
| EPS Basic Discontinuous Ops | N/A | N/A | -277.78 | 28,988.89 | N/A |
| EPS Diluted Total Ops | -25,794.84 | -67,186.56 | -36,592.68 | 38,392.30 | 13,197.40 |
| EPS Diluted Continuous Ops | -27,471.11 | -66,463.34 | -35,596.66 | -24,255.55 | -10,536.25 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -277.78 | 28,988.89 | N/A |
| EBITDA(a) | $3,890 | $-49,950 | $-30,430 | $-16,230 | $21,390 |